Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT06888700

Project on tDCS Intervention to Enhance Advanced Social Cognitive Functions in Drug Rehabilitation Individuals

Status
Enrolling By Invitation
Phase
N/A
Study type
Interventional
Enrollment
84 (estimated)
Sponsor
Shaanxi Normal University · Academic / Other
Sex
All
Age
30 Years – 60 Years
Healthy volunteers
Accepted

Summary

This project aims to explore key brain functional and biochemical indicators associated with impaired advanced social cognition through an integrated approach encompassing unconscious control, conscious control, cognitive flexibility, problem-solving, and social interaction domains. By incorporating multimodal measures spanning physiological, neural, cognitive, psychological, and behavioral dimensions, we will develop a comprehensive intervention protocol combining course-based brain stimulation and cognitive training. The study will employ a multi-timepoint, multi-level assessment framework to track the enhancement of higher cognitive functions and brain functional recovery in individuals undergoing drug rehabilitation.

Conditions

Interventions

TypeNameDescription
DEVICETranscranial direct current stimulationThe participant cohort recruited for this study consists of individuals with substance use disorder (SUD), specifically those addicted to drugs. During the intervention phase, this group will adhere to a strict non-pharmacological intervention protocol, meaning they will not receive any form of pharmacotherapy, neurosurgical intervention, or other neuromodulation-based cognitive interventions, including but not limited to techniques such as transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS). This design aims to ensure the internal validity of the study results and to exclude potential confounding effects of other interventions on neuroplasticity and cognitive function.

Timeline

Start date
2025-03-19
Primary completion
2025-04-18
Completion
2028-11-17
First posted
2025-03-21
Last updated
2025-03-21

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06888700. Inclusion in this directory is not an endorsement.